Mirae Asset Equity Savings Fund
The scheme seeks to provide capital appreciation and income distribution to the investors by using equity and equity related instruments, arbitrage opportunities, and investments in debt and money market instruments.
Growthvine rating: 5/5 — ranked #1 of 25 in category.
Fund basics
| Category | Hybrid: Equity Savings |
|---|
| NAV | ₹21.41 (as of 2026-08-21) |
|---|
| AUM | ₹1,983 Cr |
|---|
| Expense ratio | 1.16% |
|---|
| Riskometer | Moderately High |
|---|
| Fund manager | Harshad Borawake |
|---|
| Exit load | For units in excess of 15% of the investment, 1% will be charged for redemption within 90 days |
|---|
Performance & risk
| 5-year annualised return | 8.75% |
|---|
| Sharpe ratio | 0.54 |
|---|
| Standard deviation | 6.25% |
|---|
| Max drawdown | -18.25% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 135.6% of NIFTY 50 Hybrid Short Duration Debt 25:75 Index's upside and 171.7% of its downside.
Market cap allocation
| Large cap | 71.9% |
|---|
| Mid cap | 18.3% |
|---|
| Small cap | 9.9% |
|---|
Concentration
| Top 5 holdings | 13.4% |
|---|
| Top 10 holdings | 21.2% |
|---|
| Total holdings | 224 |
|---|
Top holdings
- Net Receivable / Payable — 28.9%
- TREPS — 4.1%
- ICICI Bank Ltd. — 3.5%
- HDFC Bank Ltd. — 3.2%
- 8.65% Muthoot Finance Ltd. (MD 31/01/2028) — 2.5%
- 7.88% Muthoot Finance Ltd. (MD 22/11/2028) — 2.5%
- Reliance Industries Ltd — 2.4%
- Bharti Airtel Ltd. — 2.3%
- State Bank Of India — 2.1%
- 7.45% Torrent Pharmaceuticals Ltd. (MD 19/01/2028) — 2.0%
Top sectors
- Banking & Financial — 16.5%
- Automobile — 7.2%
- Pharma & Biotech — 4.9%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 2.3% | Q2 | #11 of 25 |
| 2025 | 8.7% | Q1 (Top) | #2 of 22 |
| 2024 | 11.4% | Q2 | #8 of 22 |
| 2023 | 14.0% | Q2 | #9 of 21 |
| 2022 | 3.7% | Q2 | #7 of 19 |